Mining the bacterial genome to discover new antimicrobial molecules

Multidrug resistance is one of the major public health issues the world is facing today. However, the World Health Organization (WHO) revealed recently that there has been little progress in the development of new antibiotics to tackle drug‐resistant infections. By mining the bacterial genome databa...

Full description

Bibliographic Details
Main Authors: Wenjie Liang, Julien Diana
Format: Article
Language:English
Published: Springer Nature 2022-02-01
Series:EMBO Molecular Medicine
Online Access:https://doi.org/10.15252/emmm.202115409
_version_ 1797287865154011136
author Wenjie Liang
Julien Diana
author_facet Wenjie Liang
Julien Diana
author_sort Wenjie Liang
collection DOAJ
description Multidrug resistance is one of the major public health issues the world is facing today. However, the World Health Organization (WHO) revealed recently that there has been little progress in the development of new antibiotics to tackle drug‐resistant infections. By mining the bacterial genome database, Zhu et al, in the last issue of EMBO Molecular Medicine, report a defensin expressed by human oral actinomyces, actinomycesin, and characterize its anti‐infectious capacity (Zhu et al, 2021). They demonstrate the safety and efficacy of this bacterial antimicrobial peptide (AMP) against various bacterial strains, describe its mode of action, and validate its use as systemic drug therapy against bacterial infections in mice. This study highlights human oral bacteria as a source of antimicrobial agents that need to be considered in the future to fight multidrug‐resistant bacteria.
first_indexed 2024-03-07T18:40:54Z
format Article
id doaj.art-db7659e43b51440c92c79c554c33cb87
institution Directory Open Access Journal
issn 1757-4676
1757-4684
language English
last_indexed 2024-03-07T18:40:54Z
publishDate 2022-02-01
publisher Springer Nature
record_format Article
series EMBO Molecular Medicine
spelling doaj.art-db7659e43b51440c92c79c554c33cb872024-03-02T03:58:20ZengSpringer NatureEMBO Molecular Medicine1757-46761757-46842022-02-01142n/an/a10.15252/emmm.202115409Mining the bacterial genome to discover new antimicrobial moleculesWenjie Liang0Julien Diana1Institut Necker Enfants Malades (INEM) Institut National de la Santé et de la Recherche Médicale (INSERM) Centre National de la Recherche Scientifique (CNRS) Université de Paris Paris FranceInstitut Necker Enfants Malades (INEM) Institut National de la Santé et de la Recherche Médicale (INSERM) Centre National de la Recherche Scientifique (CNRS) Université de Paris Paris FranceMultidrug resistance is one of the major public health issues the world is facing today. However, the World Health Organization (WHO) revealed recently that there has been little progress in the development of new antibiotics to tackle drug‐resistant infections. By mining the bacterial genome database, Zhu et al, in the last issue of EMBO Molecular Medicine, report a defensin expressed by human oral actinomyces, actinomycesin, and characterize its anti‐infectious capacity (Zhu et al, 2021). They demonstrate the safety and efficacy of this bacterial antimicrobial peptide (AMP) against various bacterial strains, describe its mode of action, and validate its use as systemic drug therapy against bacterial infections in mice. This study highlights human oral bacteria as a source of antimicrobial agents that need to be considered in the future to fight multidrug‐resistant bacteria.https://doi.org/10.15252/emmm.202115409
spellingShingle Wenjie Liang
Julien Diana
Mining the bacterial genome to discover new antimicrobial molecules
EMBO Molecular Medicine
title Mining the bacterial genome to discover new antimicrobial molecules
title_full Mining the bacterial genome to discover new antimicrobial molecules
title_fullStr Mining the bacterial genome to discover new antimicrobial molecules
title_full_unstemmed Mining the bacterial genome to discover new antimicrobial molecules
title_short Mining the bacterial genome to discover new antimicrobial molecules
title_sort mining the bacterial genome to discover new antimicrobial molecules
url https://doi.org/10.15252/emmm.202115409
work_keys_str_mv AT wenjieliang miningthebacterialgenometodiscovernewantimicrobialmolecules
AT juliendiana miningthebacterialgenometodiscovernewantimicrobialmolecules